Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

BACKGROUND: Anti-tumour necrosis factor (TNF)α treatments improve outcome in severe rheumatoid arthritis (RA) and are efficacious in psoriasis and psoriatic arthritis. However recent case reports describe psoriasis occurring as an adverse event in patients with RA receiving anti-TNFα therapy. OBJECT...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Harrison, M J, Dixon, W G, Watson, K D, King, Y, Groves, R, Hyrich, K L, Symmons, D P M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2008
Aiheet:
Clinical and Epidemiological Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605571/
https://ncbi.nlm.nih.gov/pubmed/18385277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.087288
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia